These findings are consistent with the previous reports in CTCL patient samples, therefore, indicating advanced disease represented by mutated TP53 in Hut78, H9 and SeAx Sézary cells [36]. The gene discussed is TP53; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.